ACI-Houston Program Registration
This program has already taken place, to find information on upcoming programs, please check here.Program Agenda
February 9, 2019 ProgramCredit information to be announced. Click here for more detailed CME, CNE and CPE information and program objectives.
Presentations include time for Audience Response System (ARS)-assisted audience interaction as well as general question and answer time.
7:00 – 8:00 a.m.
Check-in, Onsite Registration and Networking
Session I: Introduction to Cancer Immunotherapy
8:00 – 8:05 a.m.
Welcome, Introduction, SITC Resources
8:05 – 8:35 a.m.
Basic Principles of Cancer ImmunotherapyCasey Ager, PhD – University of Texas MD Anderson Cancer Center
8:35 – 8:40 a.m.
Session II: Immunotherapy in Practice
Concurrent Session 1
8:40 – 9:20 a.m.
Immunotherapy for the Treatment of Lung CancerTina Cascone, MD, PhD – University of Texas MD Anderson Cancer Center
Immunotherapy for the Treatment of MelanomaIsabella C. Glitza, MD, PhD – University of Texas MD Anderson Cancer Center
9:20 – 9:25 a.m.
Concurrent Session 2
9:25 – 10:05 a.m.
Immunotherapy for the Treatment of Head and Neck CancerXiuning Le, MD – University of Texas MD Anderson Cancer Center
Immunotherapy for the Treatment of Genitourinary MalignanciesMatthew T. Campbell, MD – University of Texas MD Anderson Cancer Center
10:05 – 10:10 a.m.
Joint Session (all attendees)
10:10 – 10:50 a.m.
Immunotherapy for the Treatment of Hematologic MalignanciesSattva S. Neelapu, MD – University of Texas MD Anderson Cancer Center
Session III: Barriers in Practice
11:20 – Noon
Practical Barriers in Cancer Immunotherapy TreatmentLidia P. Lopez, APN-C – University of Texas MD Anderson Cancer CenterPanel Zita Lim, PA-C – University of Texas MD Anderson Cancer CenterLidia P. Lopez, APN-C – University of Texas MD Anderson Cancer Center
Session IV: The Future of Cancer Immunotherapy
Noon – 12:25 p.m.
What’s Next for Cancer Immunotherapy?Sumit K. Subudhi, MD, PhD – University of Texas MD Anderson Cancer Center
12:25 – 12:30 p.m.
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CE- and MOC-accredited programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these 4.5 hour programs will facilitate understanding of:
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
For more information, including program objectives, click here.
View the SITC Meeting Code of Conduct.
The 2018-2019 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine, the Association of Community Cancer Centers and the Hematology/Oncology Pharmacy Association.
Download PDF Flyer
Houston Marriott Medical Center/Museum District6580 Fannin StreetHouston, TX 77030
Participation in this free online pre-program course is strongly recommended as it contains information that will not be covered at the program on December 15, 2018.
This updated, interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Upon completion of the course, participants can earn continuing education credits (CME, CNE and CPE credits are available).
Click here to access this free course.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org